We are live on ! Find out more
STRO icon

Sutro Biopharma
STRO

32 hedge funds and large institutions have $137M invested in Sutro Biopharma in 2018 Q3 according to their latest regulatory filings, with 32 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

5.24% more ownership

Funds ownership: 0% → 5.24% (+5.2%)

Holders
32
Holders Change
+32
Holders Change %
–
% of All Funds
0.73%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
32
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SHI
SV Health Investors
Massachusetts
+$27.6M
2
Citadel Advisors
Citadel Advisors
Florida
+$26.4M
3
EAM
Eventide Asset Management
Massachusetts
+$18.8M
4
CCM
Camber Capital Management
Massachusetts
+$9.06M
5
CI
Cowen Inc
New York
+$6.3M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
DCM
26
DAFNA Capital Management
California
$412K +$415K +2,749 New
AGM
27
Alpine Global Management
New York
$375K +$378K +2,500 New
Walleye Trading
28
Walleye Trading
New York
$319K +$321K +2,126 New
Walleye Capital
29
Walleye Capital
New York
$201K +$202K +1,340 New
BCM
30
BlueCrest Capital Management
Jersey
$165K +$166K +1,100 New
Victory Capital Management
31
Victory Capital Management
Texas
$90K +$90.6K +600 New
UBS Group
32
UBS Group
Switzerland
$19K +$18.9K +125 New
CCA
33
Catalyst Capital Advisors
New York
$8K +$7.55K +50 New
1
2

STRO Hedge Fund Activity: Q3 2018 in Review

32 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Sutro Biopharma (STRO) for Q3 2018, worth a combined $137M.

Buyers outnumbered sellers: 32 funds opened new STRO positions and 0 closed out — a net gain of 32 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was SV Health Investors, opening a new position worth an estimated $27.6M.

  • 32 institutional investors held Sutro Biopharma (STRO) as of Q3 2018, up from 0 in Q2 2018.
  • Funds reported $137M of Sutro Biopharma stock for Q3 2018.
  • 32 funds opened new Sutro Biopharma positions in Q3 2018 and 0 closed out, a net change of +32 holders.
  • The largest Sutro Biopharma buyer in Q3 2018 was SV Health Investors, an estimated $27.6M added.

Based on aggregated 13F filings for Q3 2018.